These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 12778475

  • 1. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
    Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB.
    Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
    [Abstract] [Full Text] [Related]

  • 2. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S.
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [Abstract] [Full Text] [Related]

  • 3. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
    Wagner M, Poeck H, Jahrsdoerfer B, Rothenfusser S, Prell D, Bohle B, Tuma E, Giese T, Ellwart JW, Endres S, Hartmann G.
    J Immunol; 2004 Jan 15; 172(2):954-63. PubMed ID: 14707068
    [Abstract] [Full Text] [Related]

  • 4. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
    Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.
    Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583
    [Abstract] [Full Text] [Related]

  • 5. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A, Calcaterra C, Mènard S, Balsari A.
    J Leukoc Biol; 2007 Sep 10; 82(3):509-18. PubMed ID: 17586660
    [Abstract] [Full Text] [Related]

  • 6. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation.
    Hermann P, Van-Kooten C, Gaillard C, Banchereau J, Blanchard D.
    Eur J Immunol; 1995 Oct 10; 25(10):2972-7. PubMed ID: 7589100
    [Abstract] [Full Text] [Related]

  • 7. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
    Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.
    J Leukoc Biol; 2004 Sep 10; 76(3):585-93. PubMed ID: 15218053
    [Abstract] [Full Text] [Related]

  • 8. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells.
    Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C.
    Blood; 2000 Feb 01; 95(3):999-1006. PubMed ID: 10648415
    [Abstract] [Full Text] [Related]

  • 9. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
    Booth JS, Arsenault R, Napper S, Griebel PJ, Potter AA, Babiuk LA, Mutwiri GK.
    J Innate Immun; 2010 Feb 01; 2(5):483-94. PubMed ID: 20551621
    [Abstract] [Full Text] [Related]

  • 10. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z, Jiang Z, Liangxi W, Guofu D, Ping L, Yongling L, Wendong P, Minghai W.
    Int Immunopharmacol; 2004 Feb 01; 4(2):223-34. PubMed ID: 14996414
    [Abstract] [Full Text] [Related]

  • 11. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E, Alvarez E, Cantó E, Vidal S, Rodríguez-Sánchez JL, Sierra J, Briones J.
    Exp Hematol; 2008 Jan 01; 36(1):69-77. PubMed ID: 17959301
    [Abstract] [Full Text] [Related]

  • 12. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
    Ren T, Wen ZK, Liu ZM, Qian C, Liang YJ, Jin ML, Cai YY, Xu L.
    Cancer Invest; 2008 Jun 01; 26(5):448-55. PubMed ID: 18568766
    [Abstract] [Full Text] [Related]

  • 13. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M.
    J Leukoc Biol; 2009 Aug 01; 86(2):261-71. PubMed ID: 19401392
    [Abstract] [Full Text] [Related]

  • 14. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.
    Liu N, Ohnishi N, Ni L, Akira S, Bacon KB.
    Nat Immunol; 2003 Jul 01; 4(7):687-93. PubMed ID: 12766768
    [Abstract] [Full Text] [Related]

  • 15. Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro.
    Wattrang E, Berg M, Magnusson M.
    Vet Immunol Immunopathol; 2005 Sep 15; 107(3-4):265-79. PubMed ID: 15955566
    [Abstract] [Full Text] [Related]

  • 16. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N, Kanswal S, Puig M, Mostowski H, Verthelyi D, Akkoyunlu M.
    Eur J Immunol; 2007 Jul 15; 37(7):1785-95. PubMed ID: 17557373
    [Abstract] [Full Text] [Related]

  • 17. Activation of natural killer-like YT-INDY cells by oligodeoxynucleotides and binding by homologous pattern recognition proteins.
    Kaur H, Jaso-Friedmann L, Leary JH, Praveen K, Brahmi Z, Evans DL.
    Scand J Immunol; 2005 Oct 15; 62(4):361-70. PubMed ID: 16253123
    [Abstract] [Full Text] [Related]

  • 18. Increase in B-cell-activation factor (BAFF) and IFN-gamma productions by tonsillar mononuclear cells stimulated with deoxycytidyl-deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy.
    Goto T, Bandoh N, Yoshizaki T, Nozawa H, Takahara M, Ueda S, Hayashi T, Harabuchi Y.
    Clin Immunol; 2008 Mar 15; 126(3):260-9. PubMed ID: 18249037
    [Abstract] [Full Text] [Related]

  • 19. CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins.
    Landers CD, Bondada S.
    Clin Immunol; 2005 Sep 15; 116(3):236-45. PubMed ID: 15967728
    [Abstract] [Full Text] [Related]

  • 20. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
    Henault M, Lee LN, Evans GF, Zuckerman SH.
    J Immunol Methods; 2005 May 15; 300(1-2):93-9. PubMed ID: 15894327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.